Conjugated estrogens/bazedoxifene improved vasomotor symptoms, genitourinary syndrome of menopause, and BMD in Latin American women, with efficacy/safety similar to the global population.
Conjugated estrogens/bazedoxifene improved vasomotor symptoms, genitourinary syndrome of menopause, and BMD in Latin American women, with efficacy/safety similar to the global population.
